Mechanisms of Resistance to HER2 Target Therapy

ISSN： 1052-6773

Source： Journal of the National Cancer Institute Monographs, Vol.2011, Iss.43, 2011-10, pp. : 95-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER-2 - A Possible Target for Therapy of Metastatic Urinary Bladder Carcinoma

By Wester Kenneth Sjöström Anna Torre Manuel De La Carlsson Jörgen Malmström Per-Uno

Acta Oncologica, Vol. 41, Iss. 3, 2002-05 ,pp. : 282-288

Informa Healthcare

Access to resources Recommend Favorite

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

By Ross J.S. Fletcher J.A.

Seminars in Cancer Biology, Vol. 9, Iss. 2, 1999-04 ,pp. : 125-138

Academic Press

Access to resources Recommend Favorite

HER2 as a target in invasive urothelial carcinoma

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 844-852

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of HER2-Induced Endothelial Cell Retraction

By Carter W.

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2971-2978

Springer Publishing Company

Access to resources Recommend Favorite

Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma

By Lu Kan V Bergers Gabriele

CNS Oncology, Vol. 2, Iss. 1, 2013-01 ,pp. : 49-65

Future Medicine

Access to resources Recommend Favorite